Drugs / Repamipide
last change Jun 2018 re-read 3 minutes ago

Repamipide

Developed for
active peptic ulcer disease · gastric ulcer

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2/3 NCT02166008 Comparator Jul 2014 → Jun 2017 active peptic ulcer disease, gastric ulcer King Chulalongkorn Memorial Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Repamipide ClinicalTrials.gov intervention name — accepted as the source's own label NCT02166008 ↗